Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Curran

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Science Translational Medicine|August 26, 2021
LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockadeRonglai Shen, Michael A Postow, Matthew Adamow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 27, 2021
A Phase I Dose-Escalation Study to Evaluate the Safety and Tolerability of Evofosfamide in Combination with Ipilimumab in Advanced Solid MalignanciesAparna Hegde, Priyamvada Jayaprakash, Coline A Couillault, et al.
Cell Metabolism|June 17, 2023
Molecular mechanisms of snoRNA-IL-15 crosstalk in adipocyte lipolysis and NK cell rejuvenationYaohua Zhang, Zilong Zhao, Lisa A Huang, et al.
Immunity|May 13, 2025
Sickle cell disease induces chromatin introversion and ferroptosis in CD8<sup>+</sup> T cells to suppress anti-tumor immunityZilong Zhao, Benxia Hu, Yalan Deng, et al.
The Journal of Clinical Investigation|June 28, 2024
STING agonist 8803 reprograms the immune microenvironment and increases survival in preclinical models of glioblastomaHinda Najem, Spencer T Lea, Shashwat Tripathi, et al.
Science Translational Medicine|November 2, 2022
Hormonal therapies up-regulate MANF and overcome female susceptibility to immune checkpoint inhibitor myocarditisYaohua Zhang, Chengcao Sun, Yajuan Li, et al.
Science Advances|February 1, 2023
Tumor-associated nonmyelinating Schwann cell-expressed <i>PVT1</i> promotes pancreatic cancer kynurenine pathway and tumor immune exclusionChengcao Sun, Youqiong Ye, Zhi Tan, et al.
Cancer Discovery|April 18, 2025
Depletion of effector regulatory T cells associates with major response to induction dual immune checkpoint blockadeXianli Jiang, Nils-Petter Rudqvist, Bo Jiang, et al.
JCI Insight|March 15, 2016
Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotypeKonrad Gabrusiewicz, Benjamin Rodriguez, Jun Wei, et al.
Science Immunology|June 10, 2022
ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancerRodney Cheng-En Hsieh, Sunil Krishnan, Ren-Chin Wu, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Science Translational Medicine|August 26, 2021
LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockadeRonglai Shen, Michael A Postow, Matthew Adamow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 27, 2021
A Phase I Dose-Escalation Study to Evaluate the Safety and Tolerability of Evofosfamide in Combination with Ipilimumab in Advanced Solid MalignanciesAparna Hegde, Priyamvada Jayaprakash, Coline A Couillault, et al.
Cell Metabolism|June 17, 2023
Molecular mechanisms of snoRNA-IL-15 crosstalk in adipocyte lipolysis and NK cell rejuvenationYaohua Zhang, Zilong Zhao, Lisa A Huang, et al.
Immunity|May 13, 2025
Sickle cell disease induces chromatin introversion and ferroptosis in CD8<sup>+</sup> T cells to suppress anti-tumor immunityZilong Zhao, Benxia Hu, Yalan Deng, et al.
The Journal of Clinical Investigation|June 28, 2024
STING agonist 8803 reprograms the immune microenvironment and increases survival in preclinical models of glioblastomaHinda Najem, Spencer T Lea, Shashwat Tripathi, et al.
Science Translational Medicine|November 2, 2022
Hormonal therapies up-regulate MANF and overcome female susceptibility to immune checkpoint inhibitor myocarditisYaohua Zhang, Chengcao Sun, Yajuan Li, et al.
Science Advances|February 1, 2023
Tumor-associated nonmyelinating Schwann cell-expressed <i>PVT1</i> promotes pancreatic cancer kynurenine pathway and tumor immune exclusionChengcao Sun, Youqiong Ye, Zhi Tan, et al.
Cancer Discovery|April 18, 2025
Depletion of effector regulatory T cells associates with major response to induction dual immune checkpoint blockadeXianli Jiang, Nils-Petter Rudqvist, Bo Jiang, et al.
JCI Insight|March 15, 2016
Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotypeKonrad Gabrusiewicz, Benjamin Rodriguez, Jun Wei, et al.
Science Immunology|June 10, 2022
ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancerRodney Cheng-En Hsieh, Sunil Krishnan, Ren-Chin Wu, et al.
Pageof 9